Coronavirus can be controlled: WHO Chief points to decreasing cases

The WHO chief warned governments against opening up too quickly, as that could enable the coronavirus to come back in full strength

Coronavirus, vaccine, covid, drugs, clinical trials
WHO chief warned against coronavirus vaccine hoarding, saying it could lead to slow global economic recovery.
ANI Europe
2 min read Last Updated : Feb 02 2021 | 7:08 AM IST

The global decrease in the number of new emerging cases of COVID-19 suggests that the virus can be controlled regardless of its mutations, Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus said.

"For the third week in a row, the number of new cases of #COVID19 reported globally fell last week. There are still many countries with increasing numbers of cases, but at the global level, this is encouraging news," Tedros said at a Monday briefing, adding "It shows this virus can be controlled, even with the new variants in circulation."

The WHO chief warned governments against opening up too quickly, as that could enable the coronavirus to come back in full strength. Tedros said governments need to make appropriate adjustments, such as making quarantine measures easier to adhere to.

"Controlling the spread of the #COVID19 virus saves lives now, and saves lives later by reducing the chances of more variants emerging. And it helps to ensure vaccines remain effective," Tedros said.

On Friday, the WHO chief warned against coronavirus vaccine hoarding, saying it could lead to slow global economic recovery and most importantly a never-ending pandemic.

Since the start of the pandemic last year, more than 103 million coronavirus cases have been confirmed worldwide, with over 2.2 million fatalities, according to Johns Hopkins University.

Protests against tough coronavirus restrictions have been held in various countries as businesses are slow to recover and people are struggling amid deteriorating economic conditions.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineWorld Health Organisation

First Published: Feb 02 2021 | 7:01 AM IST

Next Story